ArticleJournal of orthopaedic case reports2025
Skip Lesion in Distal Femur with Recurrent Giant Cell Tumor of the Proximal Femur: A Very Rare Case Managed with Excision, Megaprosthesis Reconstruction, and Bone Cement Curettage.
Article in Journal of orthopaedic case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Giant cell tumor (GCT) of bone is a benign but locally aggressive tumor, commonly affecting the epiphysis of long bones in young adults. Skip lesions in GCT - defined as discontinuous tumor foci within the same bone - are exceedingly rare, particularly in the appendicular skeleton. Simultaneous recurrence and skip lesions in the same bone have been rarely documented. Case Report: We report a rare case of a 21-year-old female with a recurrent GCT of the proximal femur, previously treated with curettage, bone cementing, and fixation. Two years post-recurrence, she developed a skip lesion in the distal femur along with pulmonary metastases. Management included neoadjuvant denosumab, excision of the proximal lesion with megaprosthesis reconstruction, and curettage and cementation of the distal lesion with plate fixation. Post-operative follow-up showed significant clinical improvement and no recurrence or metastasis progression. Conclusion: This case highlights an exceptionally rare presentation of recurrent GCT with a skip lesion in the same bone and asymptomatic pulmonary metastases. Early recognition, appropriate imaging, and a multidisciplinary approach - including denosumab therapy and surgical reconstruction - are essential for favorable outcomes in such aggressive and atypical cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.